Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

AstraZeneca PLC (AZN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
10,978.0 -24.0    -0.22%
11:07:15 - Real-time Data. Currency in GBP ( Disclaimer )
  • Volume: 95,978
  • Bid/Ask: 10,976.0 / 10,980.0
  • Day's Range: 10,930.0 - 10,992.0
Type:  Equity
Market:  United Kingdom
ISIN:  GB0009895292 
SEDOL:  0989529
AstraZeneca 10,978.0 -24.0 -0.22%

AstraZeneca PLC reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was USD 10,771 million compared to USD 8,220 million a year ago. Net income was USD 360 million compared to USD 550 million a year ago. Basic earnings per share from continuing operations was USD 0.23 compared to USD 0.42 a year ago. Diluted earnings per share from continuing operations was USD 0.23 compared to USD 0.42 a year ago.For the six months, revenue was USD 22,161 million compared to USD 15,540 million a year ago. Net income was USD 746 million compared to USD 2,111 million a year ago. Basic earnings per share from continuing operations was USD 0.48 compared to USD 1.61 a year ago. Diluted earnings per share from continuing operations was USD 0.48 compared to USD 1.6 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

AZN Income Statement

Gross margin TTM 77.61%
Operating margin TTM 17.08%
Net Profit margin TTM -2.85%
Return on Investment TTM 10.66%
 Total Revenue  Net Income
Period Ending: Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Total Revenue 11390 12011 9866 8220
Gross Profit 9111 8942 6042 6027
Operating Income 878 -292 -1674 1127
Net Income 386 -347 -1652 550

AZN Balance Sheet

Quick Ratio MRQ 0.63
Current Ratio MRQ 0.96
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 87.35%
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Total Assets 100273 105363 107221 73641
Total Liabilities 63933 66095 67477 57965
Total Equity 36340 39268 39744 15676

AZN Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  14.21%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Period Length: 3 Months 12 Months 9 Months 6 Months
Cash From Operating Activities 3232 5963 4545 2826
Cash From Investing Activities -168 -11058 -10145 319
Cash From Financing Activities -3740 3649 4700 4558
Net Change in Cash -685 -1508 -973 7651
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AZN Comments

Write your thoughts about AstraZeneca PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
You We
You We Jul 26, 2022 23:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
iam new don't know anything doesnt even have a bank account can someone help?
Skhulile Sakhi
Skhulile Sakhi Jun 01, 2022 14:55
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hi I'm new here please help
Samuel Mankiwe
Samuel Mankiwe May 02, 2022 16:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I'm happy to trade with you
Ali Faizan
Ali Faizan Mar 17, 2022 12:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good.., are you free
Om Ar
Om Ar Mar 17, 2022 12:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yeh I am..
Ramakrishna Nekkanti
Ramakrishna Nekkanti Feb 10, 2022 11:28
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just buy and hold it as long as u can
Mirza Umar
Mirza Umar Jan 17, 2022 17:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ifrax Aragsan
Ifrax Aragsan Jan 11, 2022 9:55
Saved. See Saved Items.
This comment has already been saved in your Saved Items
am new here
Shaibu Oluwafemi
Shaibu Oluwafemi Dec 25, 2021 4:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anz is a good CIA to buy stock
Kelly Christina
Kelly Christina Nov 23, 2021 18:32
Saved. See Saved Items.
This comment has already been saved in your Saved Items
AZN is a good CIA to buy stocks from.
Donna Alarcon
Donna Alarcon Sep 23, 2021 9:31
Saved. See Saved Items.
This comment has already been saved in your Saved Items
how can i invest in this company?
Ian Hussey
Ian Hussey Sep 23, 2021 9:31
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy their shares ?
AR Khan
AR Khan Sep 23, 2021 9:31
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hi iam new man.
Kyaw Nyein Chan Ko
Kyaw Nyein Chan Ko Sep 23, 2021 9:31
Saved. See Saved Items.
This comment has already been saved in your Saved Items
where to buy share
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email